MEN 11270

• Description :

  MEN 11270, a cyclic decapeptide, is a B2 kinin receptor antagonist. MEN 11270 bound with high-affinity to the B2 kinin receptor constitutively expressed by WI38 human fibroblasts, inhibiting 3H-bradykinin (BK) with a pKi value of 10.3[1].

• UNSPSC :

  12352209

• Target :

  Bradykinin Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Metabolic Disease; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/men-11270.html

• Purity :

  99.15

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  O=C([C@]1([H])N(C([C@H]2NC([C@@H](NC(CNC([C@H](C[C@H]3O)N(C3)C([C@H](CCC4)N4C([C@H](CCCNC(N)=N)NC([C@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)CC5=CC=CS5)=O)=O)CC6=CC=CC=C6C1)N7[C@](CCCC8)([H])[C@]8([H])C[C@@]7([H])C(N[C@H](C(NCC2)=O)CCCNC(N)=N)=O

• Molecular Formula :

  C60H90N20O11S

• Molecular Weight :

  1299.55

• References & Citations :

  [1]Meini S, et, al. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor. J Pharmacol Exp Ther. 1999 Jun;289 (3) :1250-6.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [235082-52-7]